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CORTICOTROPIN AND CORTISONE IN DISEASES OF
THE NERVOUS SYSTEM*
H. HOUSTON MERRITTt
When corticotropin and cortisone became generally available in 1950 they
were tested as therapeutic agents in a wide variety of morbid conditions
without much consideration as to rationale. It was only natural that these
hormones should be tried in a number of diseases of the nervous system in
which the existing therapeutic agents are inadequate. It is the purpose of
this article to review critically the results reported to date and to compare
TABLE 1
TREATMENT OF PROGRESSIVE MUSCULAR DYSTROPHY WITH CORTICOTROPIN
OR CORTISONE
Clinical type Number of
Authors of dystrophy cases Results
Milhorat15 Facioscapulohumeral 3 No change
Glaser and fPseudohypertrophic 3 No change
Merritt8 |"Menopausal type" 3* No change in 2
Equivocal improvement
in 1
Shy and Juvenile type 3 No change
McEachern9 "Menopausal type" 8 7 greatly improved
1 unchanged
* Not previously reported.
them to those obtained by Dr. Gilbert Glaser and the author8 at the Neuro-
logical Institute of the Presbyterian Hospital, in the hope that the benefits
and limitations of these compounds may be determined.
A. DISEASES OF THE NEUROMUSCULAR APPARATUS
1. Progressive muscular dystrophy. Twenty cases of progressive muscu-
lar dystrophy have been treated (Table 1). In nine cases of the juvenile or
facioscapulohumeral type, there was no appreciable effect on the strength of
the patient or the course of the disease. In contrast to the poor results in
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the juvenile type of dystrophy, Shy and McEachern" reported excellent
results in the treatment of patients with a type of dystrophy which they
characterize as "menopausal dystrophy" because of the relatively late onset
of the symptoms. Good to excellent results were obtained in seven of eight
patients with this type of muscular dystrophy. Continual administration of
corticotropin or cortisone was necessary to maintain improvement. We have
treated three cases of muscular dystrophy in females, in which the onset of
symptoms was in middle life, without any significant change in the muscular
status of the patients.
2. Myotonia atrophica and myotonia congenita. Fifteen cases with myo-
tonic atrophica have been treated (Table 2). Negative results were reported
TABLE 2
THE EFFECTS OF ACTH AND CORTISONE IN THE TREATMENT OF MYOTONIA ATROPHICA
Nuimber of
Auithors 7ype of cases cases Results
Milhoratl' Myotonia atrophica 2 No change
Shy and ( Myotonia atrophica 3 Myotonia decreased
AMcEachern'5 No change in muscle
strength
Myotonia congenita 1 Myotonia disappeared
Reese and Myotonia atrophica 7 Myotonia decreased
Peters"' Slight or no improve-
ment in muscular
strength
Glaser and Myotonia atrophica 3 No change
Merritt8
by Milhorat1' (two cases) and Glaser and Merritt' (three cases). Moderate
or great improvement in the myotonic symptoms were reported by Shy and
McEachern' in three cases and by Reese and Peters' in seven patients
without any significant improvement in the muscular strength of any of
these ten patients. Shy and McEachern' also report complete abolition of
the myotonia in one patient with myotonia congenita who was treated with
corticotropin. The myotonia was greatly decreased but not abolished when
cortisone was administered by mouth.
3. Myasthenia gravis. The literature contains reports on 36 patients with
myasthenia gravis (Table 3) who have been treated with corticotropin or
cortisone. In a small percentage of the cases, administration of these com-
pounds is not accompanied by any significant change in the clinical condi-
tion of the patient. In the majority, however, there is a temporary exacerba-
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tion of the symptoms during the period of therapy, followed by a remission
of symptoms of a slight, moderate, or great degree. The remission is rarely
complete, consisting mainly of a decrease in the daily prostigmine require-
miient. These remissions are temporary, lasting only a few weeks to several
months. Repeat treatment is usually followed by recurrence of the remis-
sion. Several patients have died in the course of the treatment or within a
few weeks after the treatment had been completed.
4. Arnyotrophic lateral sclerosis. Thirteen patients with amyotrophic
lateral sclerosis have been treated with corticotropin or cortisone. No
TABLE 3
THE EFFECT OF ACTH AND CORTISONE ON MYASTHENIA GRAVIS
Author Number of cases Results
Torda and Wolff' 15 Significant partial remission in 10
Death on third day of treatment in 1
Shapiro2" 3 Partial remission in 1
No change in 1
Downhill course with death in 1
Schlezinger2' 11 Partial remission in all 11
One case died in acute relapse
Millikan and Eaton"7 5 No change in 1
Partial remission in 3
Death two weeks after treatment in 1
Soffer2' 1 Partial remission in 1*
Glaser and Merritt' 1 Partial remission with death six weeks later
* Accompanied by decrease in size of thymic tumor.
appreciable benefit was noted in three patients treated by Shy and
McEachern, one by Millikan and Eaton,1' two by Jacobson,' and seven by
Glaser and Merritt.! An increase in muscular weakness was noted in two of
the seven patients in the last series.
B. PERIPHERAL NEURITIS
Eight patients with multiple peripheral neuritides (Table 4) have been
treated with corticotropin or cortisone. No improvement was noted by Shy
and McEachern' in three patients with peripheral neuritis of unknown
cause. Improvement in muscular strength and apparent shortening of the
clinical course in patients with polyneuritis of the type classified as the
Guillain-Barre syndrome was reported in one case by Stillman and
Ganong' and in a second case by Seltzer, Lichty, and Conn.' Negative
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results were obtained by us in three cases with polyneuritis of unknown
cause, two of which were diagnosed as conforming to the Guillain-Barre
type.
C. MULTIPLE SCLEROSIS
Thirty-three patients with multiple sclerosis were treated with cortico-
tropin by Glaser and Merritt.8 Twelve (36 per cent) showed changes sug-
gestive of significant general improvement. The specific symptom complexes
most favorably affected were the spastic-paretic, cerebellar, or ataxic and
acute visual. In most instances improvement was transient, appearing only
during the course of treatment and lasting for only a week or two after the
treatment had been discontinued. A small series of cases is being kept on
TABLE 4
THE RESULTS OF TREATMENT OF POLYNEURITIS WITH CORTICOTROPIN OR CORTISONE
Number
of
Authors Type of polynteuritis cases Results
Shy and McEachern' "Unknown cause" 3 No improvement
Seltzer, et al.' "Guillain-Barre syndrome" 1 Rapid improvement
Stillman, et al.' "Guillain-Barre syndrome" 1 Rapid improvement with
relapse and subsequent
improvement
Glaser and Merritt* ("Unknown cause" 1 No improvement
"Guillain-Barre syndrome" 2 No improvement
* Not previously reported.
maintenance dosages of corticotropin or cortisone in an attempt to determine
whether long-term administration of these compounds will prevent acute
relapses of the diseases. The number of cases so treated and the period of
observation are inadequate for any conclusions.
A number of cases of multiple sclerosis have been treated by Forsham,
Thorn, and Alexander' and by Fog' with results similar to those reported
above.
Eighteen patients with acute retrobulbar neuritis, occurring as a symptom
in the course of multiple sclerosis or as an isolated phenomenon, have been
treated by McLean1' and by Gammon, Scheie, Ojers, Tyner, and King.'
McLean1' reported rapid improvement in visual acuity and decrease in size
of scotomata in two patients. Gammon and his associates' reported that les-
sening of pain, decrease of edema of the optic nerve, and increase in visual
acuity occurred one to ten days after the initiation of treatment. The final
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results in regard to vision were: Complete or almost complete return, seven;
partial return, four; no useful vision, five. This series is too small to permit
one to draw any conclusions, but it is our impression that the results re-
ported are not significantly different from those obtained with no treatment
or with other forms of treatment.
Although transient improvement may be noted in individual symptoms
in patients with multiple sclerosis who are treated with corticotropin or
cortisone, it can hardly be claimed that the-treatment of this disease with
these compounds is on the whole satisfactory.
D. EPILEPSY
It was noted by Hoefer and Glaser9 that the administration of cortico-
tropin may be accompanied by changes in the electroencephalogram. These
changes were not of the nature to suggest that this compound would be of
TABLE 5
VARIOUS NEUROLOGICAL DISEASES TREATED BY CORTICOTROPIN AND CORTISONE
(Compiled from literature)
Disease Number of patients Effect
Acute anterior poliomyelitis"' 37 No effect on clinical course
Sydenham's chorea"'8 5 No improvement 3
Improved 2
Infectious mononucleosis'0 I No effect on clinical course
Tay-Sach's disease' 1 No effect on clinical course
Wilson's disease8 2 No effect on clinical course
Parkinsonism8 3 No effect on clinical course
value in the treatment of patients with epilepsy. Furthermore, isolated con-
vulsive seizures or status epilepticus have been reported in the course of
treatment of various conditions with corticotropin or cortisone by Soffer,
et al. 26a Russell, Haserick, and Zucker,' Stephen and Noad,'7 and by
Dorfman, Apter, Smull, Bergenstal, and Richter.! In some of these cases
the exact relationship of the seizures to the administration of the hormones
is not clear, since it is known that convulsive seizures are not uncommon in
several of the conditions (lupus erythematosus, periarteritis nodosa) which
were the subject of these reports, but in other cases it seemed obvious that
the convulsions were related to the administration of the hormones.'
Russell, Haserick, and Zucker,,' however, reported that there was improve-
ment in the epileptiform seizures associated with lupus erythematosus while
under ACTH treatment, although some of their cases had convulsions for
the first time coincidental with the administration of the hormone.
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Klein and Livingston" reported improvement in the seizure incidence
and in the electroencephalograms of four of six children with epilepsy. In
the three patients treated by Glaser and Merritt,' there was no change in the
frequency of seizures. The electroencephalogram became more abnormal
in one patient.
VARIOUS CONDITIONS
Thirty-five patients with acute anterior poliomyelitis (Table 5) were
treated by Coriell, Siegel, Cook, Murphy, and Stokes.! ACTH was given to
the patients in the early stage of the disease and the study was well con-
trolled. The treatment had no effect on the course of the disease or on the
incidence of paralysis. Similar results were reported by Millikan and
Eaton1' in two cases. Experimental work in animals has shown that the ad-
ministration of these hormones may increase the susceptibility to infection
with the poliomyelitis virus.'
Two cases of Sydenham's chorea were treated with cortisone by Aronson,
Douglas, and Lewis1 and one by Glaser and Merritt' without benefit.
Schwarz," however, reported improvement in two patients with the severe
form of the disease.
One patient with infectious mononucleosis with cerebral involvement
was treated with ACTH and aureomycin by Huber, Bailey, Campbell, and
Mathiesone0 with no appreciable effect on the course of the disease.
One case of cerebromtacular degeneration (Tay-Sach's disease) was
treated by Gitman, Brusilow, and Greenblatt7 with ACTH. The treatment
did not retard the progressive course of the disease.
An editorial in the United States Armed Forces Medical Journal'm
reported that ACTH had been used with benefit in a few cases of post-
vaccinal encephalitis. No details as to symptoms, dosage, or effects of the
therapy were given.
Two patients with Wilson's disease and three patients with Parkinsonism
were treated by Glaser and Merritt' without any appreciable benefit.
DISCUSSION
Corticotropin and cortisone have been used in a variety of neurological
diseases but have not proven to be of curative value in any of them. Tem-
porary remission of symptoms occurred in many of the patients with
myasthenia gravis. There was some improvement in a few cases of multiple
sclerosis and in some patients with "menopausal dystrophy." The last
observation has been made by only one group of investigators and has as
yet not been confirmed by others.
CONCLUSIONS
Corticotropin and cortisone are of little or no value in the treatment of
the majority of neurological diseases. In a few diseases there may be a
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slight degree of improvement. Short-term administration of these hormones
in myasthenia gravis may be followed by temporary partial remissions.
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